Overview

Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
This is a placebo controlled study evaluating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder (ADHD).
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Bupropion